Frank X. Leonard, Chief Development Officer at NovoCure Ltd (NVCR), sold 2,768 shares at $78.57 ($217K) on 2022-09-06, disclosed to the SEC on 2022-09-07.
Open-market sale of $217k NVCR by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.57 | 1,384 | $109K | 50.0% |
| 2 | $78.57 | 1,384 | $109K | 50.0% |
| Total | $78.57 avg | 2,768 | $217K | 100% |
| Filing → |
| NVCR | SELL | 2026-03-03 | $231K | — | Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |